vs
Digimarc CORP（DMRC）与TriSalus Life Sciences, Inc.（TLSI）财务数据对比。点击上方公司名可切换其他公司
TriSalus Life Sciences, Inc.的季度营收约是Digimarc CORP的1.5倍（$13.2M vs $8.9M），Digimarc CORP净利率更高（-47.2% vs -73.9%，领先26.6%），TriSalus Life Sciences, Inc.同比增速更快（59.8% vs 2.9%），Digimarc CORP自由现金流更多（$895.0K vs $-2.5M），过去两年TriSalus Life Sciences, Inc.的营收复合增速更高（43.0% vs -5.3%）
迪吉马克公司是一家企业软件与服务提供商，其主打产品包含带数字标识符的软件，主要用于解决防伪问题、验证产品真伪、提升回收准确性以及实现供应链可追溯，产品可广泛应用于服装、快消品、美妆健康、汽车等多个行业领域。
TriSalus生命科学公司是一家临床阶段生物技术企业，专注于免疫肿瘤学与介入肿瘤学领域，研发专有的靶向给药技术，用于提升肝脏、胰腺等难治性实体瘤患者的治疗效果，主要在北美市场开展临床合作及业务运营。
DMRC vs TLSI — 直观对比
营收规模更大
TLSI
是对方的1.5倍
$8.9M
营收增速更快
TLSI
高出57.0%
2.9%
净利率更高
DMRC
高出26.6%
-73.9%
自由现金流更多
DMRC
多$3.4M
$-2.5M
两年增速更快
TLSI
近两年复合增速
-5.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.9M | $13.2M |
| 净利润 | $-4.2M | $-9.8M |
| 毛利率 | 63.5% | 86.7% |
| 营业利润率 | -48.2% | -24.8% |
| 净利率 | -47.2% | -73.9% |
| 营收同比 | 2.9% | 59.8% |
| 净利润同比 | 51.4% | 3.5% |
| 每股收益（稀释后） | $-0.18 | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DMRCTLSI
| Q4 25 | $8.9M | $13.2M | ||
| Q3 25 | $7.6M | $11.6M | ||
| Q2 25 | $8.0M | $11.2M | ||
| Q1 25 | $9.4M | $9.2M | ||
| Q4 24 | $8.7M | $8.3M | ||
| Q3 24 | $9.4M | $7.3M | ||
| Q2 24 | $10.4M | $7.4M | ||
| Q1 24 | $9.9M | $6.5M |
净利润DMRCTLSI
| Q4 25 | $-4.2M | $-9.8M | ||
| Q3 25 | $-8.2M | $-10.8M | ||
| Q2 25 | $-8.2M | $-8.3M | ||
| Q1 25 | $-11.7M | $-10.4M | ||
| Q4 24 | $-8.6M | $-10.1M | ||
| Q3 24 | $-10.8M | $-2.4M | ||
| Q2 24 | $-9.3M | $-4.3M | ||
| Q1 24 | $-10.3M | $-13.2M |
毛利率DMRCTLSI
| Q4 25 | 63.5% | 86.7% | ||
| Q3 25 | 58.3% | 83.5% | ||
| Q2 25 | 58.8% | 83.9% | ||
| Q1 25 | 65.0% | 83.7% | ||
| Q4 24 | 60.8% | 85.3% | ||
| Q3 24 | 62.4% | 86.3% | ||
| Q2 24 | 66.1% | 87.6% | ||
| Q1 24 | 62.5% | 85.0% |
营业利润率DMRCTLSI
| Q4 25 | -48.2% | -24.8% | ||
| Q3 25 | -109.7% | -77.9% | ||
| Q2 25 | -105.2% | -65.4% | ||
| Q1 25 | -128.9% | -79.9% | ||
| Q4 24 | -105.1% | -91.8% | ||
| Q3 24 | -120.4% | -118.9% | ||
| Q2 24 | -96.2% | -111.0% | ||
| Q1 24 | -109.2% | -180.8% |
净利率DMRCTLSI
| Q4 25 | -47.2% | -73.9% | ||
| Q3 25 | -106.9% | -93.5% | ||
| Q2 25 | -102.6% | -73.9% | ||
| Q1 25 | -125.2% | -113.2% | ||
| Q4 24 | -99.9% | -122.4% | ||
| Q3 24 | -113.9% | -32.6% | ||
| Q2 24 | -89.3% | -58.8% | ||
| Q1 24 | -104.0% | -204.5% |
每股收益（稀释后）DMRCTLSI
| Q4 25 | $-0.18 | $-0.22 | ||
| Q3 25 | $-0.38 | $-0.96 | ||
| Q2 25 | $-0.38 | $-0.27 | ||
| Q1 25 | $-0.55 | $-0.39 | ||
| Q4 24 | $-0.40 | $-0.38 | ||
| Q3 24 | $-0.50 | $-0.12 | ||
| Q2 24 | $-0.43 | $-0.21 | ||
| Q1 24 | $-0.50 | $-0.60 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.9M | $20.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $40.2M | $-33.9M |
| 总资产 | $53.0M | $35.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DMRCTLSI
| Q4 25 | $12.9M | $20.4M | ||
| Q3 25 | $12.6M | $22.7M | ||
| Q2 25 | $16.1M | $26.5M | ||
| Q1 25 | $21.6M | $13.0M | ||
| Q4 24 | $28.7M | $8.5M | ||
| Q3 24 | $33.7M | $11.3M | ||
| Q2 24 | $41.5M | $16.5M | ||
| Q1 24 | $48.9M | $4.0M |
股东权益DMRCTLSI
| Q4 25 | $40.2M | $-33.9M | ||
| Q3 25 | $41.4M | $-26.7M | ||
| Q2 25 | $46.5M | $-19.4M | ||
| Q1 25 | $50.0M | $-34.4M | ||
| Q4 24 | $61.4M | $-25.9M | ||
| Q3 24 | $70.2M | $-20.4M | ||
| Q2 24 | $77.2M | $-25.3M | ||
| Q1 24 | $84.5M | $-36.0M |
总资产DMRCTLSI
| Q4 25 | $53.0M | $35.3M | ||
| Q3 25 | $55.4M | $36.5M | ||
| Q2 25 | $60.7M | $41.3M | ||
| Q1 25 | $66.5M | $28.6M | ||
| Q4 24 | $75.8M | $24.0M | ||
| Q3 24 | $85.0M | $27.5M | ||
| Q2 24 | $93.4M | $32.4M | ||
| Q1 24 | $99.7M | $17.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $991.0K | $-2.5M |
| 自由现金流经营现金流 - 资本支出 | $895.0K | $-2.5M |
| 自由现金流率自由现金流/营收 | 10.0% | -19.1% |
| 资本支出强度资本支出/营收 | 1.1% | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-12.3M | $-19.1M |
8季度趋势，按日历期对齐
经营现金流DMRCTLSI
| Q4 25 | $991.0K | $-2.5M | ||
| Q3 25 | $-2.6M | $-3.7M | ||
| Q2 25 | $-4.7M | $-7.3M | ||
| Q1 25 | $-5.5M | $-4.5M | ||
| Q4 24 | $-4.2M | $-5.7M | ||
| Q3 24 | $-7.1M | $-10.8M | ||
| Q2 24 | $-6.8M | $-13.4M | ||
| Q1 24 | $-8.4M | $-10.9M |
自由现金流DMRCTLSI
| Q4 25 | $895.0K | $-2.5M | ||
| Q3 25 | $-2.8M | $-3.9M | ||
| Q2 25 | $-4.9M | $-7.4M | ||
| Q1 25 | $-5.5M | $-5.3M | ||
| Q4 24 | $-4.2M | $-5.8M | ||
| Q3 24 | $-7.2M | $-11.0M | ||
| Q2 24 | $-6.9M | $-13.5M | ||
| Q1 24 | $-8.5M | $-10.9M |
自由现金流率DMRCTLSI
| Q4 25 | 10.0% | -19.1% | ||
| Q3 25 | -36.9% | -33.9% | ||
| Q2 25 | -61.0% | -66.1% | ||
| Q1 25 | -59.1% | -57.3% | ||
| Q4 24 | -49.1% | -69.7% | ||
| Q3 24 | -75.7% | -149.9% | ||
| Q2 24 | -66.1% | -183.1% | ||
| Q1 24 | -85.8% | -169.3% |
资本支出强度DMRCTLSI
| Q4 25 | 1.1% | 0.3% | ||
| Q3 25 | 2.9% | 1.9% | ||
| Q2 25 | 2.5% | 0.8% | ||
| Q1 25 | 0.6% | 8.2% | ||
| Q4 24 | 0.2% | 0.6% | ||
| Q3 24 | 0.7% | 2.3% | ||
| Q2 24 | 0.3% | 0.8% | ||
| Q1 24 | 1.1% | 1.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DMRC
| Subscription | $5.3M | 60% |
| The Government | $3.6M | 41% |
TLSI
暂无分部数据
